#$%^&*AU2020202626A120200514.pdf#####Abstract: Title: Pharmaceutical Composition A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one pharmaceutically acceptable salt of glycopyrrolate; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).